- Home
- EVER vs BBOT Comparison
EVER vs BBOT Comparison
Compare EVER & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVER
- BBOT
- Stock Information
- Founded
- EVER 2008
- BBOT N/A
- Country
- EVER United States
- BBOT United States
- Employees
- EVER N/A
- BBOT N/A
- Industry
- EVER Computer Software: Programming Data Processing
- BBOT Biotechnology: Pharmaceutical Preparations
- Sector
- EVER Technology
- BBOT Health Care
- Exchange
- EVER Nasdaq
- BBOT Nasdaq
- Market Cap
- EVER 929.6M
- BBOT 822.9M
- IPO Year
- EVER 2018
- BBOT N/A
- Fundamental
- Price
- EVER $24.53
- BBOT $10.39
- Analyst Decision
- EVER Strong Buy
- BBOT Buy
- Analyst Count
- EVER 5
- BBOT 2
- Target Price
- EVER $32.40
- BBOT $24.00
- AVG Volume (30 Days)
- EVER 448.0K
- BBOT 212.5K
- Earning Date
- EVER 11-03-2025
- BBOT 01-01-0001
- Dividend Yield
- EVER N/A
- BBOT N/A
- EPS Growth
- EVER N/A
- BBOT N/A
- EPS
- EVER 1.24
- BBOT N/A
- Revenue
- EVER $615,246,000.00
- BBOT N/A
- Revenue This Year
- EVER $32.27
- BBOT N/A
- Revenue Next Year
- EVER $11.05
- BBOT N/A
- P/E Ratio
- EVER $19.72
- BBOT N/A
- Revenue Growth
- EVER 92.92
- BBOT N/A
- 52 Week Low
- EVER $16.63
- BBOT $8.70
- 52 Week High
- EVER $30.03
- BBOT $12.50
- Technical
- Relative Strength Index (RSI)
- EVER 55.75
- BBOT N/A
- Support Level
- EVER $23.22
- BBOT N/A
- Resistance Level
- EVER $24.38
- BBOT N/A
- Average True Range (ATR)
- EVER 0.79
- BBOT 0.00
- MACD
- EVER 0.18
- BBOT 0.00
- Stochastic Oscillator
- EVER 80.08
- BBOT 0.00
About EVER EverQuote Inc.
EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping, connecting consumers with insurance provider customers, which includes both carriers and agents. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.
About BBOT BridgeBio Oncology Therapeutics Inc. Common Stock
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.